FDA approves botox for spasticity

News

FDA approves botox for spasticity

12 Mar, 2010

Published over 16 years ago. See the latest and most current information on News.

Botox can now be used as a treatment for people suffering from spasticity following US Food and Drug Administration (FDA) approval.

Individuals who have tremors in their elbow, wrist and fingers could benefit from the decision, with the condition prevalent in those who have multiple sclerosis, brain injuries or have had a stroke.

Temporarily blocking signals between the nerves and muscles, botox is able to paralyse spastic limbs for a short-term period.

Director of the neurology products division of the FDA's centre for drug evaluation and research Russell Katz said it could help patients to cope with the condition more easily.

"Muscles affected by spasticity have increased stiffness and tightness, which may lead to pain, difficulties with hygiene and other activities of daily living and may affect how a patient looks," he remarked.

According to the Multiple Sclerosis International Federation, more than two million people have the disease worldwide, with weak and unsteady limbs a common symptom.

Latest News

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
WEBINAR: Delivering certainty for Section 82 with continuous water quality monitoring
Explore more Arrow
Pollution Solutions Online
AtkinsRéalis appoints Ian Dyck as global water market lead to drive growth in water infrastructure sector
Explore more Arrow
Petro Online
Safer, faster on-site density checks for aviation fuel
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow